These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32621635)

  • 1. Autoantibodies to Malondialdehyde-Acetaldehyde Are Detected Prior to Rheumatoid Arthritis Diagnosis and After Other Disease Specific Autoantibodies.
    Mikuls TR; Edison J; Meeshaw E; Sayles H; England BR; Duryee MJ; Hunter CD; Kelmenson LB; Kay Moss L; Feser ML; Wagner B; Parish MC; Deane KD; Thiele GM
    Arthritis Rheumatol; 2020 Dec; 72(12):2025-2029. PubMed ID: 32621635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis and other rheumatic conditions.
    Mikuls TR; Duryee MJ; England BR; Anderson DR; Hearth-Holmes M; Su K; Michaud K; Payne JB; Sayles H; Hunter C; McGowan JD; Klassen LW; Thiele GM
    Int Immunopharmacol; 2018 Mar; 56():113-118. PubMed ID: 29414640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enrichment of malondialdehyde-acetaldehyde antibody in the rheumatoid arthritis joint.
    Mikuls TR; Duryee MJ; Rahman R; Anderson DR; Sayles HR; Hollins A; Michaud K; Wolfe F; Thiele GE; Sokolove J; Robinson WH; Lingampalli N; Nicholas AP; Talmon GA; Su K; Zimmerman MC; Klassen LW; Thiele GM
    Rheumatology (Oxford); 2017 Oct; 56(10):1794-1803. PubMed ID: 28957552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.
    Grönwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svärd A; Stålesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmström V; Rönnelid J; Catrina AI; Lundberg K; Klareskog L
    Front Immunol; 2021; 12():627986. PubMed ID: 34093522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malondialdehyde-Acetaldehyde Adducts and Antibody Responses in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    England BR; Duryee MJ; Roul P; Mahajan TD; Singh N; Poole JA; Ascherman DP; Caplan L; Demoruelle MK; Deane KD; Klassen LW; Thiele GM; Mikuls TR
    Arthritis Rheumatol; 2019 Sep; 71(9):1483-1493. PubMed ID: 30933423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.
    Thiele GM; Duryee MJ; Anderson DR; Klassen LW; Mohring SM; Young KA; Benissan-Messan D; Sayles H; Dusad A; Hunter CD; Sokolove J; Robinson WH; O'Dell JR; Nicholas AP; Tuma DJ; Mikuls TR
    Arthritis Rheumatol; 2015 Mar; 67(3):645-55. PubMed ID: 25417811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between periodontitis and serum anti-malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis: A case-control study.
    Lee JA; Mikuls TR; Sayles HR; Thiele GM; Duryee MJ; Payne JB
    J Periodontol; 2024 Oct; 95(10):929-941. PubMed ID: 38728106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between an expanded autoantibody profile and treatment responses to biologic therapies in patients with rheumatoid arthritis.
    Petro AD; Dougherty J; England BR; Sayles H; Duryee MJ; Hunter CD; Kremer JM; Pappas DA; Robinson WH; Curtis JR; Thiele GM; Mikuls TR
    Int Immunopharmacol; 2021 Feb; 91():107260. PubMed ID: 33360371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to Malondialdehyde-Acetaldehyde Adduct Are Associated With Prevalent and Incident Rheumatoid Arthritis-Associated Interstitial Lung Disease in US Veterans.
    Aripova N; Thiele GM; Duryee MJ; Hunter CD; Yang Y; Roul P; Ascherman DP; Matson SM; Kunkel G; Cannon GW; Wysham KD; Kerr GS; Monach PA; Baker JF; Poole JA; Mikuls TR; England BR
    Arthritis Rheumatol; 2024 Sep; 76(9):1353-1363. PubMed ID: 38766737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
    Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
    Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
    Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
    Front Immunol; 2018; 9():876. PubMed ID: 29740454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of Elevations of Autoantibody Isotypes Prior to Diagnosis of Rheumatoid Arthritis.
    Kelmenson LB; Wagner BD; McNair BK; Frazer-Abel A; Demoruelle MK; Bergstedt DT; Feser ML; Moss LK; Parish MC; Mewshaw EA; Mikuls TR; Edison JD; Holers VM; Deane KD
    Arthritis Rheumatol; 2020 Feb; 72(2):251-261. PubMed ID: 31464042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis.
    Kokkonen H; Mullazehi M; Berglin E; Hallmans G; Wadell G; Rönnelid J; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2011 Feb; 13(1):R13. PubMed ID: 21291540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.
    Lakos G; Soós L; Fekete A; Szabó Z; Zeher M; Horváth IF; Dankó K; Kapitány A; Gyetvai A; Szegedi G; Szekanecz Z
    Clin Exp Rheumatol; 2008; 26(2):253-60. PubMed ID: 18565246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S; Misra R; Aggarwal A
    Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.
    da Mota LM; Dos Santos Neto LL; de Carvalho JF; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
    Rheumatol Int; 2012 Dec; 32(12):3807-12. PubMed ID: 22187055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to malondialdehyde-acetaldehyde modified low-density lipoprotein in patients with newly diagnosed inflammatory joint disease.
    Kononoff A; Hörkkö S; Pussinen P; Kautiainen H; Elfving P; Savolainen E; Arstila L; Niinisalo H; Rutanen J; Marjoniemi O; Kaipiainen-Seppänen O
    Scand J Rheumatol; 2021 Mar; 50(2):113-117. PubMed ID: 32985314
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis.
    Ateş A; Karaaslan Y; Aksaray S
    Clin Rheumatol; 2007 Apr; 26(4):499-504. PubMed ID: 16670828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of anti-CCP2 and RF isotypes and their relation to age and disease severity among Sudanese patients with rheumatoid arthritis.
    Elshafie AI; Elbagir S; Aledrissy MIE; Elagib EM; Nur MAM; Rönnelid J
    Clin Rheumatol; 2019 Jun; 38(6):1545-1553. PubMed ID: 30656490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
    Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
    Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.